Compagnie Lombard Odier SCmA Decreases Holdings in MetLife, Inc. (NYSE:MET)

Compagnie Lombard Odier SCmA decreased its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 302,894 shares of the financial services provider's stock after selling 4,404 shares during the period. Compagnie Lombard Odier SCmA's holdings in MetLife were worth $24,319,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the business. Tallon Kerry Patrick bought a new position in MetLife during the fourth quarter valued at approximately $260,000. Brighton Jones LLC lifted its stake in shares of MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock worth $347,000 after acquiring an additional 351 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in shares of MetLife during the 4th quarter worth approximately $44,000. Kingsview Wealth Management LLC lifted its stake in shares of MetLife by 48.2% during the 4th quarter. Kingsview Wealth Management LLC now owns 5,779 shares of the financial services provider's stock worth $473,000 after acquiring an additional 1,880 shares during the last quarter. Finally, Empowered Funds LLC raised its position in MetLife by 11.5% during the 4th quarter. Empowered Funds LLC now owns 11,607 shares of the financial services provider's stock valued at $950,000 after purchasing an additional 1,199 shares in the last quarter. Institutional investors own 94.99% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. decreased their target price on MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a research report on Wednesday, April 2nd. Morgan Stanley boosted their price target on MetLife from $94.00 to $99.00 and gave the company an "overweight" rating in a research note on Monday, May 19th. UBS Group boosted their price target on MetLife from $94.00 to $98.00 and gave the company a "buy" rating in a research note on Wednesday, April 2nd. Cowen restated a "buy" rating on shares of MetLife in a research note on Friday, March 7th. Finally, Piper Sandler upped their price target on MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $94.17.

MetLife Price Performance

Shares of NYSE:MET traded down $1.77 during midday trading on Friday, hitting $77.22. The company had a trading volume of 3,450,695 shares, compared to its average volume of 3,386,128. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market cap of $51.84 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 0.65 and a beta of 0.86. The business's 50-day simple moving average is $76.74 and its 200-day simple moving average is $80.62.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, April 30th. The financial services provider reported $1.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.00 by ($0.04). MetLife had a return on equity of 20.42% and a net margin of 6.19%. The business had revenue of $18.57 billion for the quarter, compared to analyst estimates of $18.06 billion. During the same period last year, the business earned $1.83 EPS. MetLife's revenue was up 15.6% compared to the same quarter last year. On average, research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 10th. Investors of record on Tuesday, May 6th were issued a $0.5675 dividend. The ex-dividend date was Tuesday, May 6th. This is a positive change from MetLife's previous quarterly dividend of $0.55. This represents a $2.27 dividend on an annualized basis and a yield of 2.94%. MetLife's dividend payout ratio (DPR) is 36.91%.

MetLife declared that its board has initiated a share buyback plan on Wednesday, April 30th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's management believes its stock is undervalued.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.